Would you recommend the following article to a politician, an athlete, a business executive, or a scientist?

Update 1: Foreign Drug Stocks in Spotlight Foreign drug stocks were in the spotlight Thursday with Food and Drug Administration news pulling the sector down. AstraZeneca PLC took a drubbing on the eve of its FDA advisory panel meeting for its orally 
